Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 1.00 |
| ▸ | CES1 | P23141 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoin SCHEMBL27696284 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL10665271 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL901258 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL28120851 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL5833429 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL145 | 1.00 | CES2 (1.00) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL28790122 | 0.98 | CES2 (0.95) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL11590328 | 0.98 | CES2 (0.95) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL28834400 | 0.98 | CES2 (0.95) | CES2CES1LMNAALDH1A1KDM4E | |
| Benzoin SCHEMBL7766715 | 0.98 | CES2 (0.95) | CES2CES1LMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004028548-A2 | INHIBITORS OF THE NITRIX OXIDE SYNTHASE III (NOS III) AS NEUROPROTECTIVE AGENTS | CARBOMER, INC. (US) | 2004-04-08 | — | — | WO | claimed |
| US-20040063612-A1 | Neuroprotective agents | CARBOMER, INC. | 2004-04-01 | — | — | US | claimed |
| EP-4658802-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | Firmenich SA (CH) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024160757-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | FIRMENICH SA (CH) | 2024-08-08 | — | — | WO | disclosed |
| EP-4396209-A1 | METHODS OF PRODUCING HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF | Amyris, Inc. (US) | 2024-07-10 | — | — | EP | disclosed |
| US-11760776-B2 | Methods for modulating protein expression in microorganisms | ORTERON (T.O) LTD. (IL) | 2023-09-19 | — | — | US | disclosed |
| WO-2023034973-A1 | METHODS OF PRODUCING HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF | Amyris, Inc. (US) | 2023-03-09 | — | — | WO | disclosed |
| CN-108250042-B | Preparation method of (S) - (-) -1,1, 2-triphenyl-1, 2-glycol | 常州沃腾化工科技有限公司 | 2021-03-02 | — | — | CN | disclosed |
| US-20190256553-A1 | NOVEL METHODS FOR MODULATING PROTEIN EXPRESSION IN MICROORGANISMS | ORTERON (T.O) LTD. (IL) | 2019-08-22 | — | — | US | disclosed |
| US-9198451-B2 | Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners | SYMRISE AG (DE) | 2015-12-01 | — | — | US | disclosed |
| EP-2220945-B1 | Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners | SYMRISE AG (DE) | 2013-03-27 | — | — | EP | disclosed |
| WO-2004028548-A2 | INHIBITORS OF THE NITRIX OXIDE SYNTHASE III (NOS III) AS NEUROPROTECTIVE AGENTS | CARBOMER, INC. (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20040063612-A1 | Neuroprotective agents | CARBOMER, INC. | 2004-04-01 | — | — | US | disclosed |
| US-20040014182-A1 | Nucleotide sequence encoding a benzaldehyde lyase, and process for stereoselectively synthesizing 2-hydroxyketones | FORSCHUNGSZENTRUM JULICH GMBH (DE) | 2004-01-22 | — | — | US | disclosed |
| JP-2002199882-A | OXIDOREDUCTASE DERIVED FROM MERIONES UNGUICULATUS, GENE ENCODING THE ENZYME, TRANSFORMANT CONTAINING THE ENZYME GENE AND METHOD FOR PRODUCING THE ENZYME | ARAKAWA CHEM IND CO LTD | 2002-07-16 | — | — | JP | disclosed |
| JP-2002171985-A | OXIDOREDUCTASE, GENE ENCODING THE ENZYME, TRANSFORMANT CONTAINING THE ENZYME GENE AND METHOD FOR PRODUCING THE ENZYME | ARAKAWA CHEM IND CO LTD | 2002-06-18 | — | — | JP | disclosed |
| US-6384228-B2 | EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| JP-2002065267-A | OXIDOREDUCTASE, GENE ENCODING THE SAME AND CLONING OF THE GENE | ARAKAWA CHEM IND CO LTD | 2002-03-05 | — | — | JP | disclosed |
| US-20020010339-A1 | METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-0190815-A2 | Process for producing aromatic diols | CELANESE CORPORATION (US) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010339-A1 | METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF | DHPS, ALAD, HAAO | CES2 742/4885CES1 705/4885LMNA 2799/4885 |
| US-20040063612-A1 | Neuroprotective agents | GAP43, NLN, NOS3 | CES2 610/4885CES1 877/4885LMNA 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.